secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPRUCE BIOSCIENCES, INC. (SPRB)
CIK:        0001683553
Form:       8-K
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001193125-25-242488
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Bali Muralidhar resigns from Spruce Biosciences board, effective Oct 15
--------------------------------------------------------------------------------

- Bali Muralidhar, Ph.D. resigned from the Board and compensation committee on October 15, 2025.
- Resignation is not due to any disagreement with the Company on operations, policies, or practices.
- No replacement named; Board size reduced by one.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1683553/000119312525242488/0001193125-25-242488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1683553/000119312525242488/sprb-20251015.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-242488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer